"PMCF Study to Evaluate Performance and Safety of Xanoftal Next"

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 2, 2022

Primary Completion Date

February 6, 2023

Study Completion Date

February 6, 2023

Conditions

Allergic ConjunctivitisDry EyeDry Eye Disease

Interventions

DEVICE

HPMC-HA eyedrops

Ocular drops based upon HPMC and HA

Trial Locations (1)

Azienda Ospedaliera Policlinico Mater Domini - Università Magna Grecia di Catanzaro, Catanzaro

All Listed Sponsors

lead

C.O.C. Farmaceutici S.r.l.

INDUSTRY